Ascend Wellness Holdings, Inc. reported first-quarter 2026 results showing revenue of $116.93M, a decline from $128M a year earlier, and a net loss of ($29.49M), with diluted loss per share of ($0.15) for the quarter.
Financial Highlights
MetricCurrent quarterPrior year quarterYoY changeRevenue¹$116.93M$128M(8.6%)Net income²($29.49M)($19.26M)(53.1%)Diluted EPS³($0.15)($0.09)(66.7%)
¹ Reported as “Revenue, net”. ² Reported as “Net loss”. ³ Reported as “loss per share attributable to Class A and Class B common stockholders — basic and diluted”.
Business Highlights
Revenue declined about 9% year-over-year as legacy dispensaries faced increased competition and price pressure, though new and partner store additions partially offset the downturn.Company is shifting channel mix from wholesale toward retail and partner stores to drive higher-margin in-store sales and reduce reliance on wholesale volume.Launched a revamped Ozone product line aimed at improving customer experience and complementing the existing portfolio.Operates 48 retail locations, including 10 partner stores, with a target footprint of 60; opened multiple dispensaries during the quarter and in early April.Manufacturing and cultivation capacity includes six CPG production facilities (about 260k sq ft canopy); sold roughly 56k lbs wholesale per quarter and plans further cultivation and dispensary expansions.
Original SEC Filing: Ascend Wellness Holdings, Inc. [ AAWH ] – 10-Q – May. 13, 2026
Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.